Clinical Outsourcing, DNA and Pharma Companies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Outsourcing

DNA

Pharma Companies

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

pharmaphorum

JULY 5, 2021

The new deal will assists the company’s focus “on advancing and innovating Parexel to meet our customers’ needs across the evolving clinical development landscape,” he added. ” The deal is subject to the usual conditions, including receipt of various approvals from regulators around the world.

Clinical Trials

Clinical Trials Clinical Trials Trials Regulation

Listicle: Maximising outsourcing models beyond time and cost

Drug Discovery World

SEPTEMBER 29, 2022

For these reasons and others, many biotech and pharmaceutical companies – along with government research labs and academic institutions – rely on contract research organizations (CROs) for drug discovery services. CROs offer an established infrastructure to develop, initiate, execute, and progress drug discovery programs towards the clinic.

Reagent

Reagent DNA Scientist Drugs

Clinical Research Informer

Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal

Listicle: Maximising outsourcing models beyond time and cost

Stay Connected